Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort

Walter Kipp, Joseph Konde-Lule, L Duncan Saunders, Arif Alibhai, Stan Houston, Tom Rubaale, Ambikaipakan Senthilselvan, Joa Okech-Ojony, Walter Kipp, Joseph Konde-Lule, L Duncan Saunders, Arif Alibhai, Stan Houston, Tom Rubaale, Ambikaipakan Senthilselvan, Joa Okech-Ojony

Abstract

Background: In sub-Saharan Africa, a shortage of trained health professionals and limited geographical access to health facilities present major barriers to the expansion of antiretroviral therapy (ART). We tested the utility of a health centre (HC)/community-based approach in the provision of ART to persons living with HIV in a rural area in western Uganda.

Methods: The HIV treatment outcomes of the HC/community-based ART program were evaluated and compared with those of an ART program at a best-practice regional hospital. The HC/community-based cohort comprised 185 treatment-naïve patients enrolled in 2006. The hospital cohort comprised of 200 patients enrolled in the same time period. The HC/community-based program involved weekly home visits to patients by community volunteers who were trained to deliver antiretroviral drugs to monitor and support adherence to treatment, and to identify and report adverse reactions and other clinical symptoms. Treatment supporters in the homes also had the responsibility to remind patients to take their drugs regularly. ART treatment outcomes were measured by HIV-1 RNA viral load (VL) after two years of treatment. Adherence was determined through weekly pill counts.

Results: Successful ART treatment outcomes in the HC/community-based cohort were equivalent to those in the hospital-based cohort after two years of treatment in on-treatment analysis (VL≤400 copies/mL, 93.0% vs. 87.3%, p = 0.12), and in intention-to-treat analysis (VL≤400 copies/mL, 64.9% and 62.0%, p = 0.560). In multivariate analysis patients in the HC/community-based cohort were more likely to have virologic suppression compared to hospital-based patients (adjusted OR = 2.47, 95% CI 1.01-6.04).

Conclusion: Acceptable rates of virologic suppression were achieved using existing rural clinic and community resources in a HC/community-based ART program run by clinical officers and supported by lay volunteers and treatment supporters. The results were equivalent to those of a hospital-based ART program run primarily by doctors.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Follow-up of patients (died, lost…
Figure 1. Follow-up of patients (died, lost to contact) in the community-based and hospital-based cohorts over the study period of two years.
Figure 2. Kaplan-Meier curves for the patients…
Figure 2. Kaplan-Meier curves for the patients who died and were lost to contact in the community-based and hospital-based cohorts over the study period of two years.

References

    1. Hladik W, Musinguzi J, Kirungi W, Opio A, Stover J . The estimated burden of HIV/AIDS in Uganda, 2005–2010. AIDS. 2008;22(4):503–510.
    1. Barnighausen T, Bloom DE, Humair S. Human resources for treating HIV/AIDS: needs, capacities and gaps. AIDS Pat Care STDs. 2007;21(11):799–812.
    1. Joint United Nations Programme on HIV/AIDS. AIDS scorecards: UNAIDS report on the global AIDS epidemic, 2010. World Health Organization, Geneva, Switzerland. 2008.
    1. Weidle PJ, Malamba S, Mwebaze R, Sozi C, Rukundo G, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients’ response, survival, and drug resistance. Lancet. 2002;360(9326):34–40.
    1. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374:2080–89. DOI: .
    1. Chang L, Alamo S, Guma S, Christopher J, Suntoke T, et al. Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda. J Acquir Immune Defic Syndr. 2009;50(3):276–282.
    1. Kipp W, Konde-Lule J, Saunders D, Alibhai A, Houston S, et al. Antiretroviral treatment in western Uganda: comparing treatment outcomes and patient mortality between a prospective community-based and hospital-based cohort. Curr HIV Res. 2010;8(2):179–185.
    1. District Information Portal. Kabarole District, Uganda. 2008. Available: . Accessed 2008 Aug 12.
    1. Ministry of Health and ORC Macro. Uganda HIV/AIDS sero-behavioural survey 2004–2005. Kampala, Uganda and Calverton, Maryland, USA. 2006.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Second Edition, Lawrence Erlbaum Associates, Hillsdale, NJ. 1988.
    1. Duff C, Kipp W, Wild TC, Rubaale T, Okech J. Barriers to accessing Highly Active Antiretroviral Therapy by HIV positive women attending an antenatal clinic in a regional hospital in western Uganda. J Internat AIDS Soc. 2010;13:37. Doi: .
    1. StataCorp. Statistical software, release 9. College Station, Texas, USA. 2005.
    1. Kamya M, Mayanza-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, et al. Predictor of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46(2):187–193.
    1. DART Virology Group and Trial Team. Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. AIDS. 2006;20(10):1391–1399.
    1. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, et al. Outcomes of two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18(6):887–895.
    1. Munoz M, Finnegan K, Zeladita J, Caldas A, Sanchez E, et al. Community-based DOT-HAART accompaniment in an urban resource-poor setting. AIDS Behav. 2010;14(3):721–730.
    1. Paris D, Ledergerber B, Weber R, Jost J, Flepp M, et al. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. AIDS Res Human Retrovir. 1999;15(18):1631–1638.
    1. Rosen S, Fox MP, Gil CJ. Patient retention in antiretroviral therapy programmes in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.
    1. Chen S, Yu J, Harries A, Bong C, Kolola-Dzimadzi R, et al. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Trop Med Internat Health. 2008;13(4):513–519.
    1. Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, et al. Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda. J Acquir Immune Defic Syndr. 2005;38(5):578–583.
    1. Wringe A, Cataldo F, Stevenson N, Fakoya A. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead of antiretroviral therapy. Health Policy Plann. 2010;25:352–362.

Source: PubMed

3
구독하다